Acute toxic epidermal necrolysis reaction post single dose pembrolizumab with preceding cephalosporin exposure: successful rechallenge with anti-PD-1 therapy
Version 2 2024-06-18, 22:56Version 2 2024-06-18, 22:56
Version 1 2021-10-20, 11:04Version 1 2021-10-20, 11:04
journal contribution
posted on 2024-06-18, 22:56authored byAJ Lomax, PIA McQuillan, A Hall, GA McArthur
Acute toxic epidermal necrolysis reaction post single dose pembrolizumab with preceding cephalosporin exposure: successful rechallenge with anti-PD-1 therapy